Moscow buys a generic drug for the treatment of HIV at a price 3.5 times lower than the original

Moscow buys a generic drug for the treatment of HIV at a price 3.5 times lower than the original

[ad_1]

Moscow authorities purchased a generic raltegravir drug for the treatment of HIV at a price of 2.8 thousand rubles. for packing. We are talking about “Rolnavir” from the Russian “Promomed”. The maximum cost of the original drug “Isentressa” from the international manufacturer MSD is six times higher – 17.2 thousand rubles. per pack, the average purchase price in 2022 was 9.7 thousand rubles.

The tender for 4.9 thousand packs of 60 tablets of 400 mg was won by the distributor “Biopreparat”, reports RBC. He reduced the maximum cost by five times – from 70.7 million rubles. up to 14.1 million rubles. The proposals of the other two bidders were higher – 14.5 million rubles. and 70.3 million rubles. (their names are not revealed).

Raltegravir is included in international and Russian recommendations for the treatment of HIV. Under government contracts until 2022, only the original Isentress was supplied. In autumn, the patent for the raltegravir molecule expired. After that, generics were registered by Promomed (Rolnavir) and Pharmasyntez (Raltegra).

According to various sources, from 850,000 to 1.1 million people with HIV live in Russia. About 400 thousand more citizens do not know about their disease.

About the reasons for different assessments of those infected with HIV – in the material “Kommersant” “Not hopeless, but disappointing”.

Leonid Uvarchev

[ad_2]

Source link